Friday, November 22, 2024
Facebook Linkedin Twitter
HomeTagsMarinus Pharmaceuticals

Marinus Pharmaceuticals

Biotechnology

Marinus Pharmaceuticals Receives Positive CHMP Opinion for ZTALMY for the Adjunctive Treatment of Seizures Associated With CDKL5 Deficiency Disorder

News Desk -
Marinus Pharmaceuticals, Inc, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced that the Committee for Medicinal Products...
Healthcare

Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone in the Treatment of Lennox-Gastaut Syndrome

Business Wire -
Marinus Pharmaceuticals, Inc, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced that the U.S. Food and Drug...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us